BOI:EPA
Boiron SA
€17.75
arrow_upward
+0.85%(+0.15) 1D
Oct 27, 10:02:46 AM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOI...
Open
€18.25
High
€18.25
Low
€17.60
Mkt. cap
311.43M
Avg. vol.
6.86K
Volume
46.00
P/E ratio
11.77
52-wk high
€32.25
52-wk low
€16.90
EPS
€1.51
Shares outstanding
17.55M
No. of employees
3K
Open
€18.25
High
€18.25
Low
€17.60
Mkt. cap
311.43M
Avg. vol.
6.86K
Volume
46.00
P/E ratio
11.77
52-wk high
€32.25
52-wk low
€16.90
EPS
€1.51
Shares outstanding
17.55M
No. of employees
3K
News stories
From web sources and news partners
www.tmgm.com
·
57 minutes ago
Dow Jones Futures gain after Wall Street opens week with gains
The Motley Fool
·
5 minutes ago
Just 10 Stocks Make Up Nearly 40% of the S&P 500. Here's an ETF That Can Help You Diversify.
The Motley Fool
·
23 minutes ago
Amazon Is Underperforming the S&P 500 and Nasdaq-100. Could Oct. 29 Mark a Turning Point?
TradingView
·
3 hours ago
Stock Market: Will S&P 500 Open Up or Down Today?
Profile
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.
Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs".
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
About Boiron SA